Cargando…
Treatment-related hemophagocytic lymphohistiocytosis due to atezolizumab: a case report and review of the literature
BACKGROUND: Immune checkpoint inhibitors avoid inhibition of T-cell responses, upregulating antitumor immune response. Moreover, a dysregulation with hyperactive immune response can be caused, some of them underdiagnosed. Hemophagocytic lymphohistiocytosis is a rare and often fatal syndrome of uncon...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531226/ https://www.ncbi.nlm.nih.gov/pubmed/36195892 http://dx.doi.org/10.1186/s13256-022-03585-3 |